Optiver Holding
LAB icon

Optiver Holding’s Standard BioTools LAB Stock Holding History

Optiver Holding’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.63K Buy
1,982
+632
+47% +$597 ﹤0.01% 2369
2026
Q1 		$1.24K Buy
1,350
+972
+257% +$1.18K ﹤0.01% 2011
2025
Q4 		$484 Sell
378
-3,486
-90% -$4.68K ﹤0.01% 2298
2025
Q3 		$5.02K Buy
+3,864
New +$5.06K ﹤0.01% 1734

Other funds holding LAB

CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $504M AUM 26.89% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Optiver Holding's LAB Position: Q2 2026 in Review

Optiver Holding increased its Standard BioTools (LAB) stake by 47% in Q2 2026, buying an estimated $597 and bringing the position to 1,982 shares worth $1.63K. The position accounts for ﹤0.01% of the portfolio, ranked #2369.

Optiver Holding first reported a position in LAB in Q3 2025 and has held it in 4 quarters since. The position peaked at $5.02K in Q3 2025. 143 funds tracked by Wall St. Rank hold LAB as of Q2 2026.

  • Optiver Holding held 1,982 shares of Standard BioTools worth $1.63K as of Q2 2026.
  • Optiver Holding bought 632 Standard BioTools shares in Q2 2026, an estimated $597.
  • Standard BioTools made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #2369 holding.
  • Optiver Holding first reported a position in Standard BioTools in Q3 2025 and has held it in 4 quarters since.
  • Optiver Holding's Standard BioTools position peaked at $5.02K in Q3 2025.
  • 143 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.